|
|
Post by esstan2001 on Nov 6, 2015 2:46:45 GMT -5
That was all Brandencourt? If I recall Witz is supposed to speak...
|
|
|
|
Post by jpg on Nov 6, 2015 2:46:58 GMT -5
|
|
|
|
Post by jpg on Nov 6, 2015 2:47:15 GMT -5
That was all Brandencourt? If I recall Witz is supposed to speak... As if she will say anything different... |
|
|
|
Post by mbseeking on Nov 6, 2015 2:49:19 GMT -5
Well at least now it is clear as day how we stand with SNY.. honestly it was not clear all the way up to the last ER.. but that started to give it away. Now we know. Knowing is always better.
|
|
|
|
Post by navpoon on Nov 6, 2015 2:49:08 GMT -5
Could this explain the TASE listing? Do they have plans to withdraw from Sanofi? Oy vey mind is running now.
|
|
|
|
Post by esstan2001 on Nov 6, 2015 2:49:38 GMT -5
Tow the ceo line...or break out detailed plan... Sadly it feels like door #1
|
|
|
|
Post by whanley7 on Nov 6, 2015 2:51:52 GMT -5
Management better have something to say Monday.
|
|
|
|
Post by mbseeking on Nov 6, 2015 2:53:48 GMT -5
Clearly the only (most) positive route now is that they confirm they have cause to cancel with SNY, give notice, and have a plan on what to do next.
|
|
|
|
Post by navpoon on Nov 6, 2015 2:54:00 GMT -5
Someone has to ask about Afrezza in Q&A...how can you discuss and show it then all of a sudden poof gone? And now all these DTC campaigns are hitting the wires....something is off.
|
|
|
|
Post by jpg on Nov 6, 2015 2:54:04 GMT -5
Hopefully they will have a plan B?
|
|
|
|
Post by mnkdorbust on Nov 6, 2015 2:55:43 GMT -5
They did mentioned they were committed to 5 products launched recently but didn't name the 5 products.
|
|
hd99
Newbie
Posts: 18 
|
Post by hd99 on Nov 6, 2015 2:55:22 GMT -5
still no Afrezza in 6 major launches
|
|
|
|
Post by jpg on Nov 6, 2015 2:55:51 GMT -5
Portfolio reshaping ended
Of coarse we remain committed to the 5 products launched recently (but does not bother to mention them).
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Nov 6, 2015 2:55:50 GMT -5
Friday script count could show continuing improvement. IMO, that's more important than what Sanofi says/does not say, in this early stage of the partnership.
|
|
|
|
Post by ezmit on Nov 6, 2015 2:57:29 GMT -5
Still to early to end partnership, but I'm questioning what Sanofi actually brings to the table.
|
|
